T. Farley, O. Meirik, and C. J. , Interpretations. Cardiovascular disease and combined oral contraceptives: reviewing the evidence and balancing the risks, Human Reproduction Update, vol.5, issue.6, pp.721-735, 1999.
DOI : 10.1093/humupd/5.6.721

M. Stampfer, W. Willet, G. Colditz, F. Speizer, and C. Hennekens, A Prospective Study of Past Use of Oral Contraceptive Agents and Risk of Cardiovascular Diseases, New England Journal of Medicine, vol.319, issue.20, pp.1313-1317, 1988.
DOI : 10.1056/NEJM198811173192004

J. Porter, J. Hunter, H. Jick, and A. Stergachis, Oral contraceptives and nonfatal cardiovascular disease, Obstet Gynecol, vol.66, pp.1-4, 1985.

J. Mant, R. Painter, and M. Vessey, Risk of myocardial infarction, angina and stroke in users of oral contraceptives: an updated analysis of a cohort study, BJOG: An International Journal of Obstetrics and Gynaecology, vol.16, issue.8, pp.890-896, 1998.
DOI : 10.1016/S0140-6736(77)90236-7

S. Siritho, A. Thrift, J. Mcneil, R. You, S. Davis et al., Risk of Ischemic Stroke Among Users of the Oral Contraceptive Pill: The Melbourne Risk Factor Study (MERFS) Group, Stroke, vol.34, issue.7, pp.1575-1580, 2003.
DOI : 10.1161/01.STR.0000077925.16041.6B

D. Petitti, S. Sidney, A. Bernstein, S. Wolf, C. Quesenberry et al., Stroke in Users of Low-Dose Oral Contraceptives, New England Journal of Medicine, vol.335, issue.1, pp.8-15, 1996.
DOI : 10.1056/NEJM199607043350102

S. Schwartz, D. Siscovick, W. Longstreth, B. Psaty, R. Beverly et al., Use of Low-Dose Oral Contraceptives and Stroke in Young Women, Annals of Internal Medicine, vol.127, issue.8_Part_1, pp.596-603, 1997.
DOI : 10.7326/0003-4819-127-8_Part_1-199710150-00003

M. Thorogood, J. Mann, M. Murphy, and M. Vessey, Fatal Stroke and Use of Oral Contraceptives: Findings from a Case-Control Study, American Journal of Epidemiology, vol.136, issue.1, pp.35-45, 1992.
DOI : 10.1093/oxfordjournals.aje.a116418

L. Gillum, S. Mamidipudi, and S. Johnston, Ischemic Stroke Risk With Oral Contraceptives, JAMA, vol.284, issue.1, pp.72-78, 2000.
DOI : 10.1001/jama.284.1.72

W. Chan, J. Ray, E. Wai, S. Ginsburg, M. Hannah et al., Risk of Stroke in Women Exposed to Low-Dose Oral Contraceptives, Archives of Internal Medicine, vol.164, issue.7, pp.741-747, 2004.
DOI : 10.1001/archinte.164.7.741

J. Baillargeon, D. Mcclish, P. Essah, and J. Nestler, Association between the Current Use of Low-Dose Oral Contraceptives and Cardiovascular Arterial Disease: A Meta-Analysis, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.7, pp.3863-3870, 2005.
DOI : 10.1210/jc.2004-1958

E. The and . Worshop, Hormones and cardiovascular health in women, Hum Reprod Update, vol.12, pp.483-97, 2006.

E. Macgregor, Migraine and use of combined hormonal contraceptives: a clinical review, Journal of Family Planning and Reproductive Health Care, vol.33, issue.3, pp.159-169, 2007.
DOI : 10.1783/147118907781004750

C. Chang, M. Donaghy, and N. Poulter, Migraine and stroke in young women: case-control study, BMJ, vol.318, issue.7175, pp.13-18, 1999.
DOI : 10.1136/bmj.318.7175.13
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC27668/pdf

L. Macclellan, W. Giles, C. J. Wozniak, M. Stern, B. Mitchell et al., Probable Migraine With Visual Aura and Risk of Ischemic Stroke: The Stroke Prevention in Young Women Study, Stroke, vol.38, issue.9, pp.2438-2445, 2007.
DOI : 10.1161/STROKEAHA.107.488395

M. Gillmer, The pill: an historical overview, Evidence-Guided Prescribing of the Pill. Carnforth, 1996.

S. Greenland, QUANTITATIVE METHODS IN THE REVIEW OF EPIDEMIOLOGIC LITERATURE1, Epidemiologic Reviews, vol.9, issue.1, pp.1-30, 1987.
DOI : 10.1093/oxfordjournals.epirev.a036298

R. Dersimonian and N. Laird, Meta-analysis in clinical trials, Controlled Clinical Trials, vol.7, issue.3, pp.177-88, 1986.
DOI : 10.1016/0197-2456(86)90046-2

Ø. Lidegaard, Oral Contraception and Risk of a Cerebral Thromboembolic Attack, Obstetrical & Gynecological Survey, vol.48, issue.10, pp.956-963, 1993.
DOI : 10.1097/00006254-199310000-00024

C. Tzourio, A. Tehindrazanarivelo, S. Iglésias, A. Alpérovitch, F. Chedru et al., Case-control study of migraine and risk of ischaemic stroke in young women, BMJ, vol.310, issue.6983, pp.830-833, 1995.
DOI : 10.1136/bmj.310.6983.830

D. Petitti, D. Siscovick, S. Sidney, S. Schwartz, C. Quesenberry et al., Norplant?? implants and cardiovascular disease, Contraception, vol.57, issue.5, pp.361-362, 1998.
DOI : 10.1016/S0010-7824(98)00036-5

L. Heinemann, A. Assmann, T. Dominh, and E. Garbe, Oral progestogen-only contraceptives and cardiovascular risk: Results from the Transnational Study on Oral Contraceptives and the Health of Young Women, The European Journal of Contraception & Reproductive Health Care, vol.4, issue.2, pp.67-73, 1999.
DOI : 10.1016/S0010-7824(97)00200-X

Ø. Lidegaard and S. Kreiner, Contraceptives and cerebral thrombosis: a five-year national case-control study???, Contraception, vol.65, issue.3, pp.197-205, 2002.
DOI : 10.1016/S0010-7824(01)00306-7

K. Singh, O. Viegas, D. Loke, and S. Ratnam, Effect of norplant?? implants on liver, lipid and carbohydrate metabolism, Contraception, vol.45, issue.2, pp.141-153, 1992.
DOI : 10.1016/0010-7824(92)90048-X

S. Graff-iversen and S. Tonstad, Use of progestogen-only contraceptives/medications and lipid parameters in women age 40 to 42 years: results of a population-based cross-sectional Norwegian Survey, Contraception, vol.66, issue.1, pp.7-13, 2002.
DOI : 10.1016/S0010-7824(02)00311-6

M. Etminan, B. Takkouche, F. Isorna, and A. Samii, Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies, BMJ, vol.330, issue.7482, p.63345596, 2005.
DOI : 10.1136/bmj.38302.504063.8F

U. Winkler, H. Howie, K. Bühler, T. Korver, T. Geurts et al., A randomized controlled double-blind study of the effects on hemostasis of two progestogen-only pills containing 75 ??g desogestrel or 30 ??g levonorgestrel, Contraception, vol.57, issue.6, pp.385-392, 1998.
DOI : 10.1016/S0010-7824(98)00045-6

J. Goldstein, M. Cushman, G. Badger, and J. Johnson, Effect of depomedroxyprogesterone acetate on coagulation parameter: a pilot study, Fertility and Sterility, vol.87, issue.6, pp.1267-1270, 2007.
DOI : 10.1016/j.fertnstert.2006.11.040

P. Ridker, M. Stampfer, and N. Rifai, Novel Risk Factors for Systemic Atherosclerosis, JAMA, vol.285, issue.19, pp.2481-2485, 2001.
DOI : 10.1001/jama.285.19.2481

R. Tracy, B. Psaty, and E. Macy, Lifetime Smoking Exposure Affects the Association of C-Reactive Protein with Cardiovascular Disease Risk Factors and Subclinical Disease in Healthy Elderly Subjects, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.17, issue.10, pp.2167-2176, 1997.
DOI : 10.1161/01.ATV.17.10.2167

M. Cushman, A. Folsom, L. Wang, N. Aleksic, R. W. Tracey et al., Fibrin fragment D-dimer and the risk of future venous thrombosis, Blood, vol.101, issue.4, pp.1243-1248, 2004.
DOI : 10.1182/blood-2002-05-1416

P. Ridker, C. Hennekens, A. Cerskus, and M. Stampfer, Plasma concentration of cross-linked fibrin degradation product (D- dimer) and the risk of future myocardial infarction among apparently healthy men, Circulation, vol.90, issue.5, pp.2236-2240, 1994.
DOI : 10.1161/01.CIR.90.5.2236

C. Vasilakis, H. Jick, and M. Del-mar-melero-montes, Risk of idiopathic venous thromboembolism in users of progestagens alone, The Lancet, vol.354, issue.9190, pp.1610-1611, 1999.
DOI : 10.1016/S0140-6736(99)04394-9

G. Scarabin, M. Plu-bureau-zeina-chakhtoura, A. Canonico, J. Gompel, and . Thalabard, Pierre-Yves Progestogen-Only Contraceptives and the Risk of Stroke: A Meta-Analysis Print ISSN, Online, vol.ISSN, pp.39-2499